H.C. Wainwright Starts Arbutus Biopharma (ABUS) at Buy, Sees 100%+ Upside
Tweet Send to a Friend
(Updated - December 17, 2020 7:58 AM EST)H.C. Wainwright analyst Ed Arce initiates coverage on Arbutus Biopharma (NASDAQ: ABUS) with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
